Treatment of the clinical NO neck in squamous cell carcinoma (SCC) of oral cavity and oropharynx remains a dilemma. None of the current imaging modalities are able to detect the presence of micrometastases in the lymph nodes of clinical NO necks reliably. The aim of this study was to determine the diagnostic properties of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) in patients clinically staged as NO. FDG PET results of 38 patients were compared to histologic specimens obtained with neck dissections or to follow-up. FDG PET performance was compared to computed tomography (CT), magnetic resonance imaging (MRI) or ultrasonography-guided fine needle aspiration cytology (USgFNAC). Sensitivity and specificity of FDG PET...
In patients with a neck metastasis from an unknown primary with non-squamous cell cancer (non-SCC) h...
Background Cervical node metastasis is one of the most significant prognostic factors in patients wi...
The uptake of 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) in neck lymph nodes of twelve patients with a s...
Treatment of the clinical NO neck in squamous cell carcinoma (SCC) of oral cavity and oropharynx rem...
Treatment of the clinical NO neck in squamous cell carcinoma (SCC) of oral cavity and oropharynx rem...
Treatment of the clinical NO neck in squamous cell carcinoma (SCC) of oral cavity and oropharynx rem...
Treatment of the clinical N0 neck in squamous cell carcinoma (SCC) of oral cavity and oropharynx rem...
Copyright 2011 Elsevier B.V., All rights reserved.Aims: To assess the value of 18F-fluorodeoxyglucos...
Background Detection of metastatic disease in head and neck cancer patients is critical to preopera...
In 1%-2% of head and neck oncology patients, the only symptom of a malignancy is a positive cervical...
In 1%-2% of head and neck oncology patients, the only symptom of a malignancy is a positive cervical...
In 1%-2% of head and neck oncology patients, the only symptom of a malignancy is a positive cervical...
In 1%-2% of head and neck oncology patients, the only symptom of a malignancy is a positive cervical...
In 1%-2% of head and neck oncology patients, the only symptom of a malignancy is a positive cervical...
In 1%-2% of head and neck oncology patients, the only symptom of a malignancy is a positive cervical...
In patients with a neck metastasis from an unknown primary with non-squamous cell cancer (non-SCC) h...
Background Cervical node metastasis is one of the most significant prognostic factors in patients wi...
The uptake of 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) in neck lymph nodes of twelve patients with a s...
Treatment of the clinical NO neck in squamous cell carcinoma (SCC) of oral cavity and oropharynx rem...
Treatment of the clinical NO neck in squamous cell carcinoma (SCC) of oral cavity and oropharynx rem...
Treatment of the clinical NO neck in squamous cell carcinoma (SCC) of oral cavity and oropharynx rem...
Treatment of the clinical N0 neck in squamous cell carcinoma (SCC) of oral cavity and oropharynx rem...
Copyright 2011 Elsevier B.V., All rights reserved.Aims: To assess the value of 18F-fluorodeoxyglucos...
Background Detection of metastatic disease in head and neck cancer patients is critical to preopera...
In 1%-2% of head and neck oncology patients, the only symptom of a malignancy is a positive cervical...
In 1%-2% of head and neck oncology patients, the only symptom of a malignancy is a positive cervical...
In 1%-2% of head and neck oncology patients, the only symptom of a malignancy is a positive cervical...
In 1%-2% of head and neck oncology patients, the only symptom of a malignancy is a positive cervical...
In 1%-2% of head and neck oncology patients, the only symptom of a malignancy is a positive cervical...
In 1%-2% of head and neck oncology patients, the only symptom of a malignancy is a positive cervical...
In patients with a neck metastasis from an unknown primary with non-squamous cell cancer (non-SCC) h...
Background Cervical node metastasis is one of the most significant prognostic factors in patients wi...
The uptake of 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) in neck lymph nodes of twelve patients with a s...